[nyschp.dop] Re: Remifentanil PCA (Out of Office)

  • From: "Michael Blumenfeld" <Michael.Blumenfeld@xxxxxxxxxxxxxxxxxxx>
  • To: "nyschp.dop@xxxxxxxxxxxxx" <nyschp.dop@xxxxxxxxxxxxx>
  • Date: Thu, 30 Apr 2015 11:20:24 -0400

I am out of the office beginning Wednesday, April 29th and will return on
Friday, May 1st. During this time I will have limited access to email and
telephone service. During normal work hours, should you have any questions for
Pharmacy leadership please contact Alejandra Hernandez at 212-562-6504 and she
can forward your inquiry the appropriate Pharmacy Manager. During off hours
and weekends, please contact the Pharmacy Manager on-call.

Thank you.

michael


Michael Blumenfeld
Director of Pharmacy Services
Bellevue Hospital Center
Office Phone: 1-212-562-6504
Fax: 1-212-562-2936
Personal Cell: 1-845-545-1220

Bellevue's Pharmacy charts the course to optimal pharmaceutical care for the
safety & welfare of our patients.

"Perino, Fred" <fperino@xxxxxxx> 04/30/15 11:19 >>>

NO

Fred J. Perino, R.Ph., M.S.
Director of Pharmacy Services
Phelps Memorial Hospital Center
& Phelps Community Pharmacy
Phone: 914-366-3302
Fax: 914-366-1530
fperino@xxxxxxx
"Pressure makes diamonds"
ITS ALL OR NOTHING

-----Original Message-----
From: nyschp.dop-bounce@xxxxxxxxxxxxx [mailto:nyschp.dop-bounce@xxxxxxxxxxxxx]
On Behalf Of Michael Blumenfeld
Sent: Thursday, April 30, 2015 10:29 AM
To: nyschp.dop@xxxxxxxxxxxxx
Subject: [nyschp.dop] Remifentanil PCA

Does anyone use remifentanil PCA in their L&D patient population?

Sent from my iPhone






Note:
This message is for the named person's use only. It may contain confidential,
proprietary or legally privileged information. No confidentiality or privilege
is waived or lost by any mistransmission. If you receive this message in
error, please immediately delete it and all copies of it from your system,
destroy any hard copies of it and notify the sender. You must not, directly or
indirectly, use, disclose, distribute, print, or copy any part of this message
if you are not the intended recipient. This organization and any of its
subsidiaries each reserve the right to monitor all e-mail communications
through its networks.

Any views expressed in this message are those of the individual sender, except
where the message states otherwise and the sender is authorized to state them
to be the views of any such entity.






Other related posts: